Extract
the late gestation fetuses. Alanine infused into the fetus did gery, at which time maternal dietary intake had returned to not alter concentrations of glucose, insulin, or glucagon in normal and fetal blood gases and pH had stabilized within plasma, These data suggest that changes in plasma concentralimits.
tions of insulin and glucagon are not important in the One group of eight animals received 2-hr constant infusions regulation of substrate metabolism during fetal!ife. Moreover, (6 mg/kg/min) by of a Holter 'Onstant the pancreatic islet /3 cell secretion response seems to mature infusion Pump. In another group of six animals, a similar earlier than the a cell response.
glucose infusion protocol was used, but at the end of 90 min the infusion rate was doubled to 12 mg/kg/min and continued for another 90 min. In two animals a continuous infusion of Speculation saline was given at similar rates over the same time period. ~h~ failure of glucagon to respond to alanine Blood was drawn at.15-min intervals throughout the infusion during fetal life suggests immaturity of glucagon control of periods for blood glucose measurement and at specified time gluconeogenesis from amino acids. The low levels of activity of intervals (OJ 457 752 05, 13' 3 1 6 5 j and 80 min); 2.5-m1 key glucagon-dependent gluconeogenic enzymes reported in blood samples were collected in syringes rinsed in 10% EDTA. liver of the newborn rat (7, 8) supports this view. These These were placed promptly into chilled tubes observations suggest the possibility that gluconeogenesis from containing EDTA plus 0.1 ml Trasylol (281, immediately amino acids may not represent a major metabolic pathway in 'Pun in a centrifuge tt 2,000 rpm, and the plasma the sheep fetus.
separated and stored at -4 until assayed for insulin and glucagon. Alanine was infused into a third group of 10 fetuses and 2 For many years glucose has been considered to be the adult sheep in a dose of 1 mM/kg of estimated body weight. principal metabolic fuel of the developing fetus. Recently, The alanine solution (29) was diluted with sterile saline; half however, it has been suggested that glucose accounts for only was given as an initial bolus injection and the remaining half about 50% of the caloric needs of the fetal sheep (13), the was infused over a 10-min period. Two-milliliter blood samples remaining energy requirement being met by amino acids, short were collected at -30, -1 5, 0, 5, 10, 15, 30,45, and 60 min. chain fatty acids, or as yet unidentified substrates (10) . The These were processed as described and analyzed for insulin, hormonal signals for control of substrate flow along intermedi-glucagon, and glucose. ary metabolic pathways in the fetus are not well delineated.
In all studies blood glucose was measured by a glucose Results of studies of fetal plasma insulin responses to a glucose oxidase method (16) . Immunoreactive insulin was measured load in several species are conflicting; insulin levels have been by a modification of the double antibody technique of Morgan described as either increasing in sheep (4, 5, 9) and man (17, and Lazarow (19) . Glucagon was assayed using a double 21) or remaining unchanged in man (2), monkeys (18) , and antibody radioimmunoassay developed in our laboratory (23) ;
sheep (25) ~g / m l .
951
T o determine substrate infusion rates, fetal body weight was estimated from a nomogram of fetal body weight versus gestational age (22) ; absolute fetal weight was determined for each fetus at the time of caesarean section. The Student paired t test was used t o compare mean results of control and experimental samples. Table 1 summarizes gestational age, fetal weight, and infusion rate of glucose for each fetus studied. All fetuses were normal weight for age and ranged in gestational age from 100-145 days at the time of the initial study.
RESULTS
Glucose, insulin, and glucagon responses to the constant infusion of glucose are depicted in Figure 1 . Steady state glucose concentrations were reached within 45 min and persisted throughout the study period at values 6-8 mg/100 ml above control levels during the 6 mg/kg/min glucose infusion. Prior studies have shown that this infusion rate was necessary to raise fetal glucose concentrations consistently. Maternal blood glucose concentrations were 20-25 mg/100 ml greater than the respective fetal values so that the maternal t o fetal gradient was maintained, and the infusions produced n o changes in maternal glucose or insulin concentrations. Figure 1 indicates that fetal insulin levels tended to increase above control values within 45 min after the beginning of the glucose infusion. However, the increment was not significant until 105 min after the infusion was begun. At this time the mean concentration was increased approximately twofold above the control level of 2 0 microunits/ml. The mean plasma glucagon concentration during the control period was approximately 320 pg/ml and tended t o decrease slightly after glucose administration. However, this decrease was not statistically significant a t any time, perhaps because of the lower level of sensitivity of 200 pg/ml in the glucagon assay.
During the course of these studies it seemed that the increment in plasma insulin in response t o glucose was greater in the fetuses studied late in gestation. T o assess this possibility, insulin responses were analyzed in two groups according t o gestational age. Early gestation fetuses were defined as less than 110 days of gestation and late gestation fetuses as greater than 135 days. The results are shown in Figure 2 ; the mean response of insulin in plasma t o the 6 mg/kg/min glucose infusion rate was greater in fetuses late in gestation and the difference was seen within 45 min after beginning the infusion. The difference was significant at both the 75-and 105-min time periods. The mean blood glucagon concentration remained unchanged during glucose infusions both early and late in gestation, although the base-line level was slightly higher late in gestation. Base-line glucose and insulin levels were not significantly different in early and late gestation. However, the small number of animals may have obscured any significant differences in the base-line glucagon levels in the early and late gestational fetuses.
The responses of blood glucose, insulin, and glucagon t o stepwise elevations of blood glucose are depicted in Figure 3 . These studies were done in the five older gestation fetuses and one young fetus. Steady state glucose concentrations were reached within 45 min as in the earlier studies. After 9 0 min a new steady state level occurred in response t o the higher glucose infusion rate. However, this second steady state glucose level was somewhat more variable than that at the lower infusion rate. The mean plasma insulin concentration was increased significantly by 45 min. A further increase over the 45-min level was present at 165 min, but at the 180-min time period the level had fallen slightly. Glucagon levels tended t o be depressed during the glucose infusions, particularly at the higher infusion rate, but because of large standard errors and the lower level of sensitivity of the assay, the changes were not significant.
The changes in blood insulin, glucagon, and glucose in response t o the fetal alanine infusions are shown in Figure 4 . In these studies, done both early (n = 4 ) and late (n = 6 ) in gestation, no significant changes were observed in any of the measured variables. In the two adult sheep, glucose tevels J GLUCOSE i2 mg iwrnin SALINE^ GLUCOSE Fig. 3 . Sequential responses of glucose in plasma (milligrams per 100 ml), insulin (microunits per milliliter), and glucagon (picograms per mil'iliter) concentrations during constant infusion of saline or glucose. Glucose was infused at two rates: 6 and 1 2 mg/kg/min. Each plotted point and line represent the mean and SE of six sheep. One fetus was 100 days gestation; the remainder were 134-145 days' gestation. The asterisks indicate the difference between the mean insulin concentrations at each time period versus base-line values. The value at 165 min was also increased (P < 0.01) over the 45-min period. * P < 0.05 ; **: P < 0.01 ; ***: P < 0.001. increased 8-10 mg/100 ml at 30 min and glucagon levels increased from base-line values of 2 12 and 103 pg/ml t o levels of 712 and 395 pg/ml, respectively, at 3 0 min.
DISCUSSION
The chronic infusion of glucose provides a more sustained physiologic stimulus for studying fetal insulin and glucagon secretion than does an acute glucose injection. Acute glucose injections are difficult t o interpret for several reasons: (1) the increased blood glucose concentrations in the fetus reverse the normal maternal-fetal blood glucose gradient so that the possibility of significant fetal t o maternal placental transfer of glucose exists at the early high fetal blood glucose levels; (2) the increase in blood glucose is not prolonged enough or sustained enough t o establish steady state conditions for insulin secretion. These factors may help t o explain some of the earlier conflicting data regarding insulin secretion responses in several species. Reported insulin responses to glucose injections in both the monkey (1 8), rat (1 5), and man (21) were minimal, whereas, in the fetal sheep, a response t o acute glucose o r fructose injection has been observed by some authors (4, 5, 9) and not by others (25) . The present results suggest that some of this variation may relate t o the degree and duration of the stimulus.
As noted in Figure 1 , fetal serum insulin levels were not significantly increased until 105 min after beginning the chronic infusion. However, we did not measure serum concentrations before 4 5 min. Studies of fetal rat ~a n c r e a t i c insulin release conducted in vitro also have shown a delayed and obtunded response t o glucose, and this response can be markedly enhanced by the addition of caffeine or theophylline t o the incubation media (15) . Similar enhancement of insulin release by theophylline has been reported in the monkey fetus by Chez et al. (1 1). These investigators found that glucose combined with theophylline elicited a prompt rise in plasma insulin in the primate fetus, whereas glucose or theophylline alone did not. Insulin levels were also promptly increased by the infusion of the dibutyryl derivative of cyclic 3',5 -adenosine monophosphate t o the fetus. These observations suggest that the l&itaiion in fetal insulin release in response t o glucose may relate t o immaturity of the ( 3 cell cyclic AMP system. However, it is clear from the present studies that the pancreatic islet 0 cell in the fetal sheep is capable of responding with release of immunoreactive insulin after relatively modest increments in mean blood sugar concentration if the increment is sustained. These studies also indicate that the fetal insulin response t o a glucose stimulus increases in the sheep with increasing gestational age, although baseline insulin concentrations were similar. Thus, in the fetal sheep, as in the human fetus (2), the insulin secretory response t o glucose is delayed and obtunded but appears to improve with increasing gestational age. Under the steady state conditions of the present studies, the glucose disposal rate represents the sum of the glucose infusion rate and any continuing maternal t o fetal placental glucose transfer. Since the latter was not quantified, it is not possible t o estimate precisely disposal from the rate of infusion. However, the steady state plasma glucose concentration in response t o the 6 mg/kg/min glucose infusion rate was similar both early and late in gestation, which suggests either that glucose disposal in the fetus is not insulin dependent or that the effect of insulin on glucose disposal decreased with age. The latter possibility seems less likely.
Glucagon has been identified in the fetal pancreas early in gestation (6) . Moreover, in man and sheep, the placenta is impermeable t o glucagon (1, 24) , as t o most other peptide hormones, so that fetal blood glucagon must be derived from the fetal pancreas. Earlier data in humans also suggest that glucagon levels in fetal blood are low and respond minimally t o arginine infusion (6) . The present results in the sheep fetus support this suggestion and indicate that pancreatic glucagon also is unresponsive t o alanine in this species. In contrast, Wise et al. (27) described increased glucagon concentrations in cord blood of newborn infants after administration of alanine t o women in labor. In addition, we have reported recently that alanine administration t o newborn infants during the first 24 h r of life evokes modest increases in blood glucagon (23) .
The blood glucagon levels in the present study probably reflect some gut glucagon o r glucagon-like activity as well as pancreatic glucagon, since the antibody used for the radioimmunoassay shows some cross-reaction with gut glucagon standards. However, this in no way invalidates the results, since there is little or no gastrointestinal stimulation during intravenous glucose and alanine infusions. Moreover, the base-line glucagon levels in the fetal sheep in the present study are similar to those reported by Alexander et al. (3) .
Felig and collaborators (12) have postulated the existence in adult man of a glucose-alanine cycle. Alanine has been shown t o be a potent stimulus for glucagon secretion in both the dog (20) and man (26) . Moreover, we have confirmed that alanine will evoke glucagon secretion in the adult sheep and in the human neonate (23) . The results of the present studies indicate that alanine is not an inportant stimulus for glucagon secretion in the sheep fetus; the glucagon response t o alanine infusion was minimal or absent (Fig. 4 ).
SUMMARY
Studies of insulin and glucagon concentrations in plasma have been conducted in fetal sheep in utero via indwelling vascular catheters. Chronic glucose infusions and acute alanine infusions were used as stimuli. The pancreatic insulin secretory response t o glucose was relatively obtunded but some maturation of this response was observed with advancing gestational age. The pancreatic glucagon response was minimal in all fetuses studied. The pancreatic islet P cell (insulin) secretion mechanism or mechanisms appear t o mature earlier than the (Y cell (glucagon) secretion mechanism.
Extract Speculation
A total of 104 of 693 Negro infants (15.0%) had moderate or small amounts of hemoglobin Barts visible on starch gel electrophoresis. Moderate amounts were found in 21 infants (3.0%) and small amounts in 83 infants (12.0%). In 17 Negro infants judged to have moderate amounts of Hb Barts, the quantitation showed 2.0-9.3% with a mean of 5.4 f 2.1 (1 SD). A significant decrease in mean cell volume and mean cell hemoglobin was found in the Negro neonate with more than 2% Hb Barts studied at 4 days of age. In 10 Negro infants with more than 2.0% Hb Barts studied at 4 days of age, the a/(P + y) ratio was 0.97 + 0.06 (1 SD) (range 0.88-1.06). In nine infants aged 5-24 months who had more than 2.0% Hb Barts in the newborn period, including six infants studied in the first group, the mean a/P ratio was 0.74 f 0.06, (range 0.65-0.83).
Each of the nine infants with more than 2.0% Hb Barts at birth had marked microcytosis and hypochromia at 5-24 months despite adequate iron therapy. Two newborn infants with moderate levels of Hb Barts at birth (8.2% and 6.8%) and balanced total globin synthesis had no free radioactive a chain by gel filtration studies. Our studies indicate clearly that the presence of more than 2% Hb Barts in the newborn period denotes the presence of a-thalassemia trait.
In a group of Negro newborn infants, 3% had more than 2% Hb Barts. These infants had the genetic disorder, a-thalassemia trait. An additional 12% of the infants had elevated levels of Hb Barts between 1% and 2%. This group may also have an a-thalassemia disorder, as has been shown in other racial groups. The absence of hydrops fetalis due to a-thalassemia in Negro neonates suggests that the molecular defect of a-thalassemia detected in Negro neonates differs from that seen in Orientals in that it is not associated with a complete absence of a-chain synthesis.
a-Thalassemia is a common genetic disorder of hemoglobin synthesis which occurs in many ethnic groups, including Chinese (18), Thai (23, 34), Italians (18) , and American Negroes (27) . Extensive population studies in Thailand have shown a correlation between the a-thalassemia syndromes and the amount of Hb Barts present in the neonatal period (22, 23, 33, 34) . Hb Barts is a tetramer of the y-globin chain (y4), a polypeptide which is found in association with a chain in fetal hemoglobin (Hb F a 2 y2).
The significance of Hb Barts in Negro neonates is controversial. Weatherall (35) has claimed that the presence of
